Humedix Statistics
Total Valuation
Humedix has a market cap or net worth of KRW 299.38 billion.
Market Cap | 299.38B |
Enterprise Value | n/a |
Important Dates
The last earnings date was Tuesday, November 12, 2024.
Earnings Date | Nov 12, 2024 |
Ex-Dividend Date | Jun 27, 2024 |
Share Statistics
Humedix has 10.40 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 10.40M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +0.00% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 8.02% |
Float | 6.18M |
Valuation Ratios
The trailing PE ratio is 29.88 and the forward PE ratio is 6.95.
PE Ratio | 29.88 |
Forward PE | 6.95 |
PS Ratio | 2.44 |
PB Ratio | 2.15 |
P/TBV Ratio | n/a |
P/FCF Ratio | 55.02 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.06, with a Debt / Equity ratio of 0.23.
Current Ratio | 3.06 |
Quick Ratio | 2.00 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.16 |
Debt / FCF | 6.02 |
Interest Coverage | 7.16 |
Financial Efficiency
Return on equity (ROE) is 7.26% and return on invested capital (ROIC) is 6.05%.
Return on Equity (ROE) | 7.26% |
Return on Assets (ROA) | 5.11% |
Return on Capital (ROIC) | 6.05% |
Revenue Per Employee | 447.55M |
Profits Per Employee | 36.55M |
Employee Count | 248 |
Asset Turnover | 0.57 |
Inventory Turnover | 3.77 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.07% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -24.07% |
50-Day Moving Average | 32,258.00 |
200-Day Moving Average | 32,058.75 |
Relative Strength Index (RSI) | 30.68 |
Average Volume (20 Days) | 118,953 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Humedix had revenue of KRW 110.99 billion and earned 9.06 billion in profits. Earnings per share was 963.99.
Revenue | 110.99B |
Gross Profit | 44.07B |
Operating Income | 15.99B |
Pretax Income | 11.34B |
Net Income | 9.06B |
EBITDA | 28.26B |
EBIT | 15.99B |
Earnings Per Share (EPS) | 963.99 |
Balance Sheet
The company has 54.35 billion in cash and 32.73 billion in debt, giving a net cash position of 21.62 billion or 2,079.87 per share.
Cash & Cash Equivalents | 54.35B |
Total Debt | 32.73B |
Net Cash | 21.62B |
Net Cash Per Share | 2,079.87 |
Equity (Book Value) | 141.95B |
Book Value Per Share | 13,398.54 |
Working Capital | 79.77B |
Cash Flow
In the last 12 months, operating cash flow was 19.18 billion and capital expenditures -13.74 billion, giving a free cash flow of 5.44 billion.
Operating Cash Flow | 19.18B |
Capital Expenditures | -13.74B |
Free Cash Flow | 5.44B |
FCF Per Share | 523.45 |
Margins
Gross margin is 39.70%, with operating and profit margins of 14.41% and 8.17%.
Gross Margin | 39.70% |
Operating Margin | 14.41% |
Pretax Margin | 10.22% |
Profit Margin | 8.17% |
EBITDA Margin | 25.46% |
EBIT Margin | 14.41% |
FCF Margin | 4.90% |
Dividends & Yields
This stock pays an annual dividend of 550.00, which amounts to a dividend yield of 2.08%.
Dividend Per Share | 550.00 |
Dividend Yield | 2.08% |
Dividend Growth (YoY) | -23.33% |
Years of Dividend Growth | n/a |
Payout Ratio | 41.51% |
Buyback Yield | 1.06% |
Shareholder Yield | 3.14% |
Earnings Yield | 3.35% |
FCF Yield | 1.82% |
Stock Splits
The last stock split was on December 27, 2018. It was a forward split with a ratio of 1.07.
Last Split Date | Dec 27, 2018 |
Split Type | Forward |
Split Ratio | 1.07 |
Scores
Humedix has an Altman Z-Score of 3.88.
Altman Z-Score | 3.88 |
Piotroski F-Score | n/a |